The Full Wiki

More info on SLC3A2

SLC3A2: Wikis

Advertisements

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

From Wikipedia, the free encyclopedia

edit
Solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2

PDB rendering based on 2dh2.
Available structures
2dh2, 2dh3
Identifiers
Symbols SLC3A2; 4F2; 4F2HC; 4T2HC; CD98; CD98HC; MDU1; NACAE
External IDs OMIM158070 MGI96955 HomoloGene1795 GeneCards: SLC3A2 Gene
RNA expression pattern
PBB GE SLC3A2 200924 s at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez 6520 17254
Ensembl ENSG00000168003 ENSMUSG00000010095
UniProt P08195 Q3TIP1
RefSeq (mRNA) NM_001012661 NM_008577
RefSeq (protein) NP_001012679 NP_032603
Location (UCSC) Chr 11:
62.38 - 62.41 Mb
Chr 19:
8.77 - 8.78 Mb
PubMed search [1] [2]

4F2 cell-surface antigen heavy chain is a protein that in humans is encoded by the SLC3A2 gene.[1][2]

This gene is a member of the solute carrier family and encodes a cell surface, transmembrane protein with an alpha amylase domain. The protein exists as the heavy chain of a heterodimer, covalently bound through di-sulfide bonds to one of several possible light chains. It associates with integrins and mediates integrin-dependent signaling related to normal cell growth and tumorigenesis. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.[2]

Contents

Interactions

SLC3A2 has been shown to interact with SLC7A7.[3]

See also

References

  1. ^ Teixeira S, Di Grandi S, Kuhn LC (Aug 1987). "Primary structure of the human 4F2 antigen heavy chain predicts a transmembrane protein with a cytoplasmic NH2 terminus". J Biol Chem 262 (20): 9574–80. PMID 3036867. 
  2. ^ a b "Entrez Gene: SLC3A2 solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2". http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=6520. 
  3. ^ Pfeiffer, R; Rossier G, Spindler B, Meier C, Kühn L, Verrey F (Jan. 1999). "Amino acid transport of y+L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein-associated amino acid transporter family". EMBO J. (ENGLAND) 18 (1): 49–57. doi:10.1093/emboj/18.1.49. ISSN 0261-4189. PMID 9878049. 

Further reading

  • Rochelle JM, Watson ML, Oakey RJ, Seldin MF (1992). "A linkage map of mouse chromosome 19: definition of comparative mapping relationships with human chromosomes 10 and 11 including the MEN1 locus.". Genomics 14 (1): 26–31. doi:10.1016/S0888-7543(05)80278-2. PMID 1358795. 
  • Michalak M, Quackenbush EJ, Letarte M (1986). "Inhibition of Na+/Ca2+ exchanger activity in cardiac and skeletal muscle sarcolemmal vesicles by monoclonal antibody 44D7.". J. Biol. Chem. 261 (1): 92–5. PMID 2416754. 
  • Gottesdiener KM, Karpinski BA, Lindsten T, et al. (1989). "Isolation and structural characterization of the human 4F2 heavy-chain gene, an inducible gene involved in T-lymphocyte activation.". Mol. Cell. Biol. 8 (9): 3809–19. PMID 3265470. 
  • Lindsten T, June CH, Thompson CB, Leiden JM (1989). "Regulation of 4F2 heavy-chain gene expression during normal human T-cell activation can be mediated by multiple distinct molecular mechanisms.". Mol. Cell. Biol. 8 (9): 3820–6. PMID 3265471. 
  • Quackenbush E, Clabby M, Gottesdiener KM, et al. (1987). "Molecular cloning of complementary DNAs encoding the heavy chain of the human 4F2 cell-surface antigen: a type II membrane glycoprotein involved in normal and neoplastic cell growth.". Proc. Natl. Acad. Sci. U.S.A. 84 (18): 6526–30. doi:10.1073/pnas.84.18.6526. PMID 3476959. 
  • Lumadue JA, Glick AB, Ruddle FH (1988). "Cloning, sequence analysis, and expression of the large subunit of the human lymphocyte activation antigen 4F2.". Proc. Natl. Acad. Sci. U.S.A. 84 (24): 9204–8. doi:10.1073/pnas.84.24.9204. PMID 3480538. 
  • Posillico JT, Srikanta S, Eisenbarth G, et al. (1987). "Binding of monoclonal antibody (4F2) to its cell surface antigen on dispersed adenomatous parathyroid cells raises cytosolic calcium and inhibits parathyroid hormone secretion.". J. Clin. Endocrinol. Metab. 64 (1): 43–50. PMID 3782435. 
  • Hemler ME, Strominger JL (1982). "Characterization of antigen recognized by the monoclonal antibody (4F2): different molecular forms on human T and B lymphoblastoid cell lines.". J. Immunol. 129 (2): 623–8. PMID 6177771. 
  • Peters PG, Kamarck ME, Hemler ME, et al. (1983). "Genetic and biochemical characterization of a human surface determinant on somatic cell hybrids: the 4F2 antigen.". Somatic Cell Genet. 8 (6): 825–34. doi:10.1007/BF01543022. PMID 6187076. 
  • Francke U, Foellmer BE, Haynes BF (1983). "Chromosome mapping of human cell surface molecules: monoclonal anti-human lymphocyte antibodies 4F2, A3D8, and A1G3 define antigens controlled by different regions of chromosome 11.". Somatic Cell Genet. 9 (3): 333–44. doi:10.1007/BF01539142. PMID 6190235. 
  • Haynes BF, Hemler ME, Mann DL, et al. (1981). "Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes.". J. Immunol. 126 (4): 1409–14. PMID 7204970. 
  • Ohgimoto S, Tabata N, Suga S, et al. (1995). "Molecular characterization of fusion regulatory protein-1 (FRP-1) that induces multinucleated giant cell formation of monocytes and HIV gp160-mediated cell fusion. FRP-1 and 4F2/CD98 are identical molecules.". J. Immunol. 155 (7): 3585–92. PMID 7561057. 
  • Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.". Gene 138 (1-2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298. 
  • Andersson B, Wentland MA, Ricafrente JY, et al. (1996). "A "double adaptor" method for improved shotgun library construction.". Anal. Biochem. 236 (1): 107–13. doi:10.1006/abio.1996.0138. PMID 8619474. 
  • Ohgimoto S, Tabata N, Suga S, et al. (1996). "Regulation of human immunodeficiency virus gp160-mediated cell fusion by antibodies against fusion regulatory protein 1.". J. Gen. Virol. 77 ( Pt 11): 2747–56. doi:10.1099/0022-1317-77-11-2747. PMID 8922468. 
  • Courseaux A, Grosgeorge J, Gaudray P, et al. (1997). "Definition of the minimal MEN1 candidate area based on a 5-Mb integrated map of proximal 11q13. The European Consortium on Men1, (GENEM 1; Groupe d'Etude des Néoplasies Endocriniennes Multiples de type 1).". Genomics 37 (3): 354–65. PMID 8938448. 
  • Yu W, Andersson B, Worley KC, et al. (1997). "Large-scale concatenation cDNA sequencing.". Genome Res. 7 (4): 353–8. PMID 9110174. 
  • Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library.". Gene 200 (1-2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149. 
  • Tabata N, Ido M, Suga S, et al. (1998). "Protein tyrosine kinase activation provides an early and obligatory signal in anti-FRP-1/CD98/4F2 monoclonal antibody induced cell fusion mediated by HIV gp160.". Med. Microbiol. Immunol. 186 (2-3): 115–23. doi:10.1007/s004300050053. PMID 9403839. 

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

Advertisements

Advertisements






Got something to say? Make a comment.
Your name
Your email address
Message